Imerys (ENXTPA:NK) Q3 Results Lift Guidance As Losses Linger

Simply Wall St · 23h ago

Imerys walked into its Q3 2026 release with the share price at €25.34, after a steady run over the past quarter that left many investors quietly optimistic. The headline was clear: the minerals specialist lifted full year adjusted earnings guidance, backed by €884m in quarterly revenue and a positive net profit from ongoing activities.

The stock reaction now pits emotion against arithmetic. Short term traders are fixating on near term profit pressure and past losses, while the updated guidance and improving operating trends tell a calmer story. That gap between fear and fundamentals is where today’s move really lives.

Love the higher full year earnings guidance from Imerys, but concerned about near term profit pressure and past losses clouding the picture? Compare this setup with a curated list of companies in our list of solid balance sheet and fundamentals stocks (202 results)

Q3 2026 Earnings Summary

  • Revenue (Q3 2026 vs. Q3 2025): €884 million vs. €827 million (up about 6.9%)
  • Net Income from Ongoing Activities (Q3 2026 vs. Q3 2025): €43 million vs. €39 million (up about 10.3%)
  • Basic EPS (Q2 2026 vs. Q2 2025): €0.57 vs. €0.56 (up about 1.9%). Basic EPS for Q3 2026 was not disclosed in the figures provided
  • Trailing 12-Month Net Result (Q3 2026 vs. Q3 2025): Net loss of €426.8 million vs. net profit of €158 million (swing to a sizeable loss on a trailing basis)

Imerys lifted full-year EBITDA guidance after steady Q3 momentum. Ask Charlie what’s really behind Imerys’ guidance upgrade.

ENXTPA:NK Trailing 12-Month Earnings & Revenue History as at Oct 2026
ENXTPA:NK Trailing 12-Month Earnings & Revenue History as at Oct 2026

Imerys Bull Case Hinges On Execution, Not Hype

For bullish investors, the key claim is that Imerys can shift from volume projects to efficiency and higher value minerals while keeping capital discipline tight.

"The main thing that has to go right is that Imerys continues to convert its pipeline in conductive additives and Graphite & Carbon into profitable sales growth while keeping tight capital discipline on large lithium and industrial projects."

Q3 adds evidence on the first leg of that story. Energy transition materials posted double digit YTD growth and Q3 organic expansion of 21%, outpacing the group and supporting the mix shift argument. Raised adjusted EBITDA guidance and a 9M margin of 7.1% indicate cost programs are feeding through, even while large lithium projects remain mothballed or partnered, in line with the capital discipline claim.

The price and this Narrative do not agree. → Uncover what this Narrative says Imerys is actually worth.

Imerys Bear Case: Impairments Still Shadow Margin Story

Bearish investors worry that repeated write downs turn Project Horizon from an efficiency engine into a repair job.

"Although Imerys is delivering Horizon savings that support current EBITDA, the EUR 41m impairment linked to this program signals that further footprint and cost actions may be less about upside and more about defending profitability."

Q3 delivery tells both sides of that story. Imerys lifts adjusted EBITDA guidance and reports a 7.1% 9M margin, so cost plans are clearly working. Yet the trailing 12 month net loss of €426.8m, driven in part by restructuring and project impairments, shows those fears are not fully neutralized by this improvement.

Spot Earnings Gaps In Plain View

Imerys just showed how earnings headlines and trailing losses can send mixed messages across a single report. The real opportunity is finding stocks that could be undervalued before the market corrects them.

  • Company 1 - 48% below our estimate - focus on higher margin direct sales as efficiency gains support richer product categories.
  • Company 2 - 22% below our estimate - sell subscription connectivity hardware so physical AI and satellite users deepen software and services usage.
  • Company 3 - 38% below our estimate - expand manufacturing and installation capacity so higher margin protective films and coatings follow new demand.

Those are three of them. See the full list of 201 companies trading below our fair value estimates →